Herbalife Ltd. (HLF) Given Average Recommendation of “Hold” by Analysts
Herbalife Ltd. (NYSE:HLF) has been assigned an average rating of “Hold” from the six brokerages that are currently covering the firm. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $67.43.
HLF has been the topic of several research reports. Zacks Investment Research raised shares of Herbalife from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a research note on Friday, August 5th. Pivotal Research reaffirmed a “buy” rating and issued a $90.00 target price on shares of Herbalife in a report on Sunday, July 17th. TheStreet cut shares of Herbalife from a “buy” rating to a “hold” rating in a report on Tuesday, August 9th. Finally, SunTrust Banks Inc. reaffirmed a “neutral” rating and issued a $66.00 target price on shares of Herbalife in a report on Friday, August 5th.
Herbalife (NYSE:HLF) traded up 1.98% on Tuesday, reaching $62.44. 419,192 shares of the company traded hands. The stock’s 50-day moving average is $61.90 and its 200-day moving average is $61.60. Herbalife has a 1-year low of $42.26 and a 1-year high of $72.22. The stock has a market capitalization of $5.80 billion, a price-to-earnings ratio of 21.40 and a beta of 1.83.
Herbalife (NYSE:HLF) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.29 EPS for the quarter, topping the consensus estimate of $1.21 by $0.08. Herbalife had a net margin of 5.55% and a negative return on equity of 2,099.28%. The business had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same quarter in the previous year, the firm posted $1.24 earnings per share. Herbalife’s quarterly revenue was up 3.4% on a year-over-year basis. Equities research analysts expect that Herbalife will post $4.83 EPS for the current year.
In other Herbalife news, major shareholder Carl C. Icahn bought 306,846 shares of the business’s stock in a transaction that occurred on Wednesday, August 31st. The stock was bought at an average cost of $60.39 per share, for a total transaction of $18,530,429.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Ibelis Fleming sold 9,729 shares of the business’s stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $64.86, for a total transaction of $631,022.94. The disclosure for this sale can be found here. Insiders own 4.91% of the company’s stock.
A number of hedge funds have recently made changes to their positions in HLF. NINE MASTS CAPITAL Ltd acquired a new stake in shares of Herbalife during the first quarter valued at about $123,000. First Midwest Bank Trust Division acquired a new stake in shares of Herbalife during the second quarter valued at about $209,000. Bbva Compass Bancshares Inc. acquired a new stake in shares of Herbalife during the second quarter valued at about $211,000. Sei Investments Co. raised its stake in shares of Herbalife by 10.1% in the second quarter. Sei Investments Co. now owns 3,673 shares of the company’s stock valued at $215,000 after buying an additional 337 shares during the period. Finally, Virginia Retirement Systems ET AL acquired a new stake in shares of Herbalife during the second quarter valued at about $222,000.
Herbalife Company Profile
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. The Company’s segments include North America; Mexico; South & Central America; Europe, Middle East, and Africa (EMEA); Asia Pacific, and China.
Receive News & Stock Ratings for Herbalife Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Ltd. and related stocks with our FREE daily email newsletter.